PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

The National Multiple Sclerosis Society commits over $18 million for research to drive pathways to cures

2025-05-01
(Press-News.org) The National Multiple Sclerosis Society has committed $18.1 million in multi-year funding to support research projects aligned with its Pathways to Cures roadmap that focuses on three critical areas: stopping MS, restoring function and ending MS. 

The new projects include 16 research grants and 28 training fellowships and early career awards in the United States and internationally. The Society is committed to driving the best, most promising science and to training the next generation of pioneering MS researchers. More than 100 senior scientists from research institutions around the country, and a special committee of people affected by MS, all contribute to the process of deciding what research to fund.

The newly funded projects include:

A clinical trial to investigate whether the MIND diet can protect the brain and improve symptoms in people with MS. A study of abnormalities in glucose and oxygen use in the brains of people with progressive MS. An investigation of virus patterns in blood and spinal cord fluid samples that may help predict who is at high risk of developing MS.  These projects are part of the Society’s annual investment of over $30 million to support more than 200 new and ongoing MS research studies around the world, including support and leadership for the International Progressive MS Alliance – a global effort to accelerate the development of effective treatments for people with progressive MS. 

Learn more about the research funded by the National MS Society:
Summaries of the newly funded research projects (.pdf)
A list of Society-supported research projects, sorted by location (.pdf)
A list of Society-supported research projects, sorted by topic (.pdf)

###

About Multiple Sclerosis

Multiple sclerosis is an unpredictable disease of the central nervous system. Currently there is no cure. Symptoms vary from person to person and may include disabling fatigue, mobility challenges, cognitive changes, and vision issues. An estimated 1 million people live with MS in the United States. Early diagnosis and treatment are critical to minimize disability. Significant progress is being made to achieve a world free of MS.

About the National Multiple Sclerosis Society

The National MS Society, founded in 1946, is the global leader of a growing movement dedicated to creating a world free of MS. The Society funds cutting-edge research for a cure, drives change through advocacy and provides programs and services to help people affected by MS live their best lives. Connect to learn more and get involved: nationalmssociety.org, Facebook, X (formerly known as Twitter), Instagram, YouTube or 1-800-344-4867.

END


ELSE PRESS RELEASES FROM THIS DATE:

Virtual pulmonary rehabilitation programs are safe, effective for people with COPD

2025-05-01
Miami (May 1, 2025) – Virtual pulmonary rehabilitation is a safe, effective alternative to traditional pulmonary rehabilitation programs for people with chronic obstructive pulmonary disease (COPD) who also require supplemental oxygen, according to a new report. The report is published in the March 2025 issue of Chronic Obstructive Pulmonary Diseases: Journal of the COPD Foundation, a peer-reviewed, open-access journal. COPD is an inflammatory lung disease, comprising several conditions, including ...

Good karma for me, bad karma for you

2025-05-01
WASHINGTON – Many people around the world believe in karma – that idea that divine justice will punish people who do bad deeds and reward those who good. But that belief plays out differently for oneself versus others, according to research published by the American Psychological Association. People are more likely to believe that they’ve earned good things in their own life through karmic merit, while bad things that happen to other people are due to karmic punishment, according ...

Studies underscore occupational health hazards for Cath lab personnel and highlight need for lead-less solutions

2025-05-01
Washington, D.C. – May 1, 2025 – Analyses from the (Ergonomics in the Cardiac Catheterization Laboratory (ERGO-CATH) study show the traditional approach using a lead apron causes 43% of interventional cardiologists to experience discomfort, building on existing consensus of the significant occupational health risks that exist in the catheterization (cath) lab. The data were presented today at the Society for Cardiovascular Angiography & Interventions (SCAI) 2025 Scientific Sessions in Washington, D.C. The cath lab is a designated ...

Single antiplatelet therapy reduced risk of mortality and major bleeding in patients undergoing transcatheter aortic valve replacement by half

2025-05-01
Washington, D.C. – MAY 1, 2025 – Findings from the Transfusion Requirements in Transcatheter Aortic Valve Implantation (TRITAVI) registry demonstrate that single antiplatelet therapy (SAPT) after transcatheter aortic valve replacement (TAVR) is associated with a significantly lower incidence of six-month mortality and major bleeding risk compared to dual antiplatelet therapy (DAPT). The late-breaking data were presented today at the Society for Cardiovascular Angiography & Interventions (SCAI) 2025 Scientific Sessions. The current standard of care following TAVR is SAPT, which involves the use of only one ...

Women and Black patients face higher risks and unequal access in advanced cardiovascular procedures

2025-05-01
Press Contacts: Gavin Stern gstern@scai.org, 202-644-8561 Annika Parrish  aparrish@brgcommunications.com, 703-793-8356    WOMEN AND BLACK PATIENTS FACE HIGHER RISKS AND UNEQUAL ACCESS IN ADVANCED CARDIOVASCULAR PROCEDURES   Women Experience Higher Risk of Serious Cardiovascular Events After Transcatheter Aortic Valve Implantation and Left Atrial Appendage Occlusion Device Placement Black Patients with Chronic Limb-Threatening Ischemia Almost 50% More Likely to Require Major Amputation Yet 10% ...

In iron-dependent cell death, lysosome destabilization is key

2025-05-01
Fukuoka, Japan—The duplication and division of cells is critical to keeping all multicellular organisms alive. But the opposite process is equally important: cell death. Controlled death of cells, or programmed cell death, is also necessary for the proper development and function of the body. It has also been a focus of researchers developing treatments for cancer by finding ways to activate the cell death of cancer cells themselves. Ferroptosis is a recently discovered form of programmed cell death and has been a promising target for the ...

Stenting improves long-term survival for patients with complete blockages undergoing percutaneous coronary intervention

2025-05-01
Washington, D.C. – MAY 1, 2025 – In patients undergoing chronic total occlusion (CTO) percutaneous coronary intervention (PCI), stenting demonstrated improved long-term survival and fewer cardiac arrests at one year. The late-breaking data were presented today at the Society for Cardiovascular Angiography & Interventions (SCAI) 2025 Scientific Sessions. Coronary artery disease (CAD) is the most common type of heart disease and a leading cause of death worldwide. CTO PCI is a minimally invasive procedure to treat CAD by reopening blocked arteries with a catheter and stent. CTO PCI is a ...

Nationwide study finds ambulatory surgery centers treat 15% more patients in socially vulnerable areas for cardiac interventions

2025-05-01
Washington, D.C. – MAY 1, 2025 – The first study evaluating Medicare patients undergoing percutaneous coronary intervention (PCI) in ambulatory surgery centers (ASCs) demonstrated good safety outcomes, such as mortality and adverse event rates at 30 days, compared to outpatient hospital departments, but were less likely to use certain technologies. The late-breaking data were presented today at the Society for Cardiovascular Angiography & Interventions (SCAI) 2025 Scientific Sessions. Ambulatory surgery centers (ASCs) are non-hospital facilities that provide same-day surgical or procedural ...

Intestinal depletion of TM6SF2 exacerbates high-fat diet-induced metabolic dysfunction-associated steatotic liver disease through the gut-liver axis

2025-05-01
Background and Aims Metabolic dysfunction-associated steatotic liver disease (MASLD), is the most common form of chronic liver disease worldwide. This study aimed to explore the role of TM6SF2 in high-fat diet (HFD)-induced MASLD through the gut-liver axis. Methods The TM6SF2 gut-specific knockout (TM6SF2 GKO) mouse was constructed using CRISPR/Cas9 technology. TM6SF2 GKO and wild-type (CON) mice were fed either a HFD or a control diet for 16 weeks to induce MASLD. Blood, liver, and intestinal lipid content, as well as gut microbiota and serum metabolites, were then analyzed. Results TM6SF2 GKO ...

New research shows one in four patients in early cardiogenic shock experience poorer outcomes

2025-05-01
Washington, D.C. – MAY 1, 2025 – In one of the largest studies of early cardiogenic shock (CS) patients, where blood flow is still functioning to vital organs, researchers demonstrated that 26% experienced worse outcomes, including care escalation, CS deterioration, or in-hospital mortality. The data were presented today as late-breaking clinical research at the Society for Cardiovascular Angiography & Interventions (SCAI) 2025 Scientific Sessions. CS is a life-threatening condition in which the heart cannot pump enough blood to meet the body’s needs. As a result, your blood pressure may suddenly drop to dangerous levels, and if CS isn’t diagnosed and treated ...

LAST 30 PRESS RELEASES:

Duke and Duke-NUS’ joint cross-population research to uncover "East-West" differences in disease and care

Scientists to ‘spy’ on cancer- immune cell interactions using quantum technology breakthrough

Tech savvy users have most digital concerns

Making lighter work of calculating fluid and heat flow

Normalizing blood sugar can halve heart attack risk

Lowering blood sugar cuts heart attack risk in people with prediabetes

Study links genetic variants to risk of blinding eye disease in premature infants

Non-opioid ‘pain sponge’ therapy halts cartilage degeneration and relieves chronic pain

AI can pick up cultural values by mimicking how kids learn

China’s ecological redlines offer fast track to 30 x 30 global conservation goal

Invisible indoor threats: emerging household contaminants and their growing risks to human health

Adding antibody treatment to chemo boosts outcomes for children with rare cancer

Germline pathogenic variants among women without a history of breast cancer

Tanning beds triple melanoma risk, potentially causing broad DNA damage

Unique bond identified as key to viral infection speed

Indoor tanning makes youthful skin much older on a genetic level

Mouse model sheds new light on the causes and potential solutions to human GI problems linked to muscular dystrophy

The Journal of Nuclear Medicine ahead-of-print tip sheet: December 12, 2025

Smarter tools for peering into the microscopic world

Applications open for funding to conduct research in the Kinsey Institute archives

Global measure underestimates the severity of food insecurity

Child survivors of critical illness are missing out on timely follow up care

Risk-based vs annual breast cancer screening / the WISDOM randomized clinical trial

University of Toronto launches Electric Vehicle Innovation Ontario to accelerate advanced EV technologies and build Canada’s innovation advantage

Early relapse predicts poor outcomes in aggressive blood cancer

American College of Lifestyle Medicine applauds two CMS models aligned with lifestyle medicine practice and reimbursement

Clinical trial finds cannabis use not a barrier to quitting nicotine vaping

Supplemental nutrition assistance program policies and food insecurity

Switching immune cells to “night mode” could limit damage after a heart attack, study suggests

URI-based Global RIghts Project report spotlights continued troubling trends in worldwide inhumane treatment

[Press-News.org] The National Multiple Sclerosis Society commits over $18 million for research to drive pathways to cures